Cyprotex (CRX)

5.38p
   
  • Change Today:
    -0.13p
  • 52 Week High: 6.50p
  • 52 Week Low: 2.88p
  • Currency: UK Pounds
  • Shares Issued: 223.69m
  • Volume: 19,299
  • Market Cap: £12.02m
  • RiskGrade: 284

Cyprotex Overview

Cyprotex is in the pharmaceuticals & biotechnology sector and is currently trading at 5.38p per share. In the last year Cyprotex's share price has ranged from 2.88p to 6.50p.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 8.5% 12.5%
ROCE 14.4%  
Latest F'cast
P/E 14.1 10.3
PEG 0.5 0.3
Pr/Revenue 1.6 1.3
Pr/Book 1.8  
Latest F'cast
Revenue 33.5% 21.4%
PBT 192.3% 103.5%
EPS 25.8% 37.0%
DPS n/a n/a

Cyprotex Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 3.63 (0.54) (0.35)p n/a n/a n/a n/a 0.0%
31-Dec-08 5.18 0.54 0.36p 7.3 n/a n/a n/a 0.0%
31-Dec-09 5.00 0.46 0.26p 12.5 n/a -28% n/a 0.0%
31-Dec-10 5.92 0.20 0.31p 14.9 0.8 +19% n/a 0.0%
31-Dec-11 7.91 0.59 0.39p 10.3 0.4 +26% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Cyprotex Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 9.60 1.20 0.53p 10.3 0.3 +37% n/a 0.0%
31-Dec-13 11.15 1.95 0.87p 6.3 0.1 +63% n/a 0.0%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Cyprotex Company Announcements

Product Launch 03-May-2012 07:00 RNS
Final Results 22-Mar-2012 07:00 RNS
Pre-Closed Trading Update 12-Jan-2012 07:00 RNS

Latest Cyprotex Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Cyprotex Market Data

Currency UK Pounds
Share Price 5.38p
Change Today -0.13p
% Change -2.27 %
52 Week High 6.50p
52 Week Low 2.88p
Volume 19,299
Shares Issued 223.69m
Market Cap £12.02m
RiskGrade 284

Cyprotex Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average
82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average
Price Trend
93.94% above the market average93.94% above the market average93.94% above the market average93.94% above the market average93.94% above the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Income Not Available
Growth
84.12% above the market average84.12% above the market average84.12% above the market average84.12% above the market average84.12% above the market average
87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average

Cyprotex Dividends

No dividends found

Trades for 31-May-2012

Time Volume / Share Price
09:57 9,299 @ 5.35p
08:07 10,000 @ 5.25p

Cyprotex Key Personnel

CEO Anthony Baxter
CFO John Dootson

Top of Page